DE69717453T2 - Amid derivate - Google Patents
Amid derivateInfo
- Publication number
- DE69717453T2 DE69717453T2 DE69717453T DE69717453T DE69717453T2 DE 69717453 T2 DE69717453 T2 DE 69717453T2 DE 69717453 T DE69717453 T DE 69717453T DE 69717453 T DE69717453 T DE 69717453T DE 69717453 T2 DE69717453 T2 DE 69717453T2
- Authority
- DE
- Germany
- Prior art keywords
- group
- agents
- ring
- substituted
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 239000003524 antilipemic agent Substances 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229940126904 hypoglycaemic agent Drugs 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004542 purin-6-yl group Chemical group N1=CN=C2N=CNC2=C1* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14409996 | 1996-06-06 | ||
| JP7311697 | 1997-03-26 | ||
| PCT/JP1997/001875 WO1997046560A1 (fr) | 1996-06-06 | 1997-06-02 | Derives d'amides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69717453D1 DE69717453D1 (de) | 2003-01-09 |
| DE69717453T2 true DE69717453T2 (de) | 2003-07-10 |
Family
ID=26414260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69717453T Expired - Fee Related DE69717453T2 (de) | 1996-06-06 | 1997-06-02 | Amid derivate |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6166016A (de) |
| EP (1) | EP0915093B1 (de) |
| JP (1) | JP3870298B2 (de) |
| KR (1) | KR100298523B1 (de) |
| CN (1) | CN1066448C (de) |
| AT (1) | ATE228518T1 (de) |
| AU (1) | AU716633B2 (de) |
| CA (1) | CA2257222C (de) |
| DE (1) | DE69717453T2 (de) |
| TW (1) | TW470736B (de) |
| WO (1) | WO1997046560A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2315736A1 (en) * | 1998-01-05 | 1999-07-15 | Eisai Co., Ltd. | Purine compounds and adenosine a2 receptor antagonist as preventive or therapeutic for diabetes mellitus |
| DE60118521T2 (de) * | 2000-01-07 | 2006-10-12 | Universitaire Instelling Antwerpen | Purin derivate, ihre herstellung und verwendung |
| JP2004516297A (ja) * | 2000-12-20 | 2004-06-03 | ソシエテ・ド・コンセイユ・ド・ルシエルシエ・エ・ダアツプリカーション・シヤンテイフイツク・（エス．セー．エール．アー．エス） | サイクリン依存性キナーゼ（ｃｄｋ）及びグリコーゲンシンターゼキナーゼ−３（ｇｓｋ−３）の阻害剤 |
| FR2818278B1 (fr) * | 2000-12-20 | 2003-02-28 | Sod Conseils Rech Applic | Inhibiteurs de kinases dependantes des cyclines (cdk) et de la glycogene synthase kinase-3 (gsk-3) |
| CA2433778A1 (en) * | 2001-02-14 | 2002-08-22 | William Glen Harter | Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| FR2842809A1 (fr) * | 2002-07-26 | 2004-01-30 | Greenpharma Sas | NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION |
| US7129239B2 (en) * | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
| JP2008506714A (ja) * | 2004-07-16 | 2008-03-06 | サネシス ファーマシューティカルズ， インコーポレイテッド | オーロラキナーゼインヒビターとして有用なチエノピリミジン |
| WO2006040645A1 (en) * | 2004-10-11 | 2006-04-20 | Ranbaxy Laboratories Limited | N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma |
| CA2670636A1 (en) * | 2006-11-27 | 2008-06-05 | H. Lundbeck A/S | Heteroaryl amide derivatives |
| SG11201804901WA (en) | 2015-12-22 | 2018-07-30 | SHY Therapeutics LLC | Compounds for the treatment of cancer and inflammatory disease |
| US10588894B2 (en) | 2017-06-21 | 2020-03-17 | SHY Therapeutics LLC | Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
| CA3100923A1 (en) * | 2018-06-04 | 2019-12-12 | Exscientia Ltd | Pyrazolopyrimidine compounds as adenosine receptor antagonists |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3551428A (en) * | 1956-02-10 | 1970-12-29 | Ciba Geigy Corp | New 1- (or 2-) substituted 4-mercapto-pyrazolo(3,4-d)pyrimidines |
| US4638010A (en) * | 1985-02-28 | 1987-01-20 | E. R. Squibb & Sons, Inc. | Ester substituted aminoalkanoylureido amino and imino acid and ester compounds |
| US5391739A (en) * | 1989-03-29 | 1995-02-21 | Merrell Dow Pharmaceuticals Inc. | Selective adenosine receptor agents |
| JP2585462B2 (ja) * | 1989-10-25 | 1997-02-26 | 株式会社大塚製薬工場 | ピラゾロ［１，５―ａ］ピリミジン誘導体 |
| ATE174917T1 (de) * | 1991-04-22 | 1999-01-15 | Otsuka Pharma Co Ltd | Pyrazolo(1,5-a>pyrimidinderivate und sie enthaltende antiinflammatorische mittel |
| TW444018B (en) * | 1992-12-17 | 2001-07-01 | Pfizer | Pyrazolopyrimidines |
| RU2124015C1 (ru) * | 1992-12-17 | 1998-12-27 | Пфайзер Инк. | Производные пирроло [2,3-d] пиримидинов, фармацевтическая композиция, пирроло [2,3-d] пиримидины, производные пиррола |
| TW530047B (en) * | 1994-06-08 | 2003-05-01 | Pfizer | Corticotropin releasing factor antagonists |
| US5869486A (en) * | 1995-02-24 | 1999-02-09 | Ono Pharmaceutical Co., Ltd. | Fused pyrimidines and pyriazines as pharmaceutical compounds |
-
1997
- 1997-06-02 US US09/194,727 patent/US6166016A/en not_active Expired - Fee Related
- 1997-06-02 CN CN97195345A patent/CN1066448C/zh not_active Expired - Fee Related
- 1997-06-02 KR KR1019980709969A patent/KR100298523B1/ko not_active IP Right Cessation
- 1997-06-02 WO PCT/JP1997/001875 patent/WO1997046560A1/ja active IP Right Grant
- 1997-06-02 AU AU29778/97A patent/AU716633B2/en not_active Ceased
- 1997-06-02 JP JP50040898A patent/JP3870298B2/ja not_active Expired - Fee Related
- 1997-06-02 CA CA002257222A patent/CA2257222C/en not_active Expired - Fee Related
- 1997-06-02 DE DE69717453T patent/DE69717453T2/de not_active Expired - Fee Related
- 1997-06-02 EP EP97924299A patent/EP0915093B1/de not_active Expired - Lifetime
- 1997-06-02 AT AT97924299T patent/ATE228518T1/de not_active IP Right Cessation
- 1997-06-06 TW TW086107762A patent/TW470736B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2257222C (en) | 2002-08-20 |
| KR100298523B1 (ko) | 2001-09-06 |
| KR20000016395A (ko) | 2000-03-25 |
| EP0915093A4 (de) | 1999-08-18 |
| EP0915093A1 (de) | 1999-05-12 |
| ATE228518T1 (de) | 2002-12-15 |
| CN1066448C (zh) | 2001-05-30 |
| US6166016A (en) | 2000-12-26 |
| DE69717453D1 (de) | 2003-01-09 |
| AU2977897A (en) | 1998-01-05 |
| JP3870298B2 (ja) | 2007-01-17 |
| WO1997046560A1 (fr) | 1997-12-11 |
| CN1221419A (zh) | 1999-06-30 |
| TW470736B (en) | 2002-01-01 |
| CA2257222A1 (en) | 1997-12-11 |
| AU716633B2 (en) | 2000-03-02 |
| EP0915093B1 (de) | 2002-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2054899T3 (es) | Derivados de 2'-desoxi-5-fluorouridina. | |
| DE69717453D1 (de) | Amid derivate | |
| ATE243697T1 (de) | Substitutierte heterozyclische derivate als crf antagonisten | |
| DE69728761D1 (de) | Heterocyclisch substituierte benzolderivate und herbizide | |
| ATE282630T1 (de) | Dolastatin-derivate | |
| FI956270A0 (fi) | Piperdiinijohdannaisia ja menetelmä niiden valmistamiseksi | |
| DE69431576T2 (de) | Isoxazole Derivate und ihre Verwendung als Herbizide | |
| ES2088537T3 (es) | Derivados de piranil cianoguanidina. | |
| ATE180468T1 (de) | Anthranilsäure derivate | |
| FI933357A (fi) | Foerfarande foer framstaellning av benzamider | |
| DK0842661T3 (da) | Anvendelse af estrogenagonister og -antagonister til fremstilling af et lægemiddel til behandling af atherosclerose, uafhængigt af lipidsænkning | |
| ATE125532T1 (de) | Nitromethylenverbindungen, deren herstellung und deren verwendung als pestizide. | |
| DE69813605D1 (de) | Benzofuranderivate | |
| DE69613710D1 (de) | Benzoxazepinverbindungen, ihre herstellung und verwendung als lipidsenker | |
| ES2128440T3 (es) | Derivado de 4-alcoxi-2,6-di-t-butilfenol. | |
| CA2273303A1 (en) | Thienylsulfonylamino(thio)carbonyl compounds | |
| DE69817214D1 (de) | Azaring-ether-derivate und ihre verwendung als nicotinic-ach-rezeptormodulatoren | |
| DE60013994D1 (de) | 1,2-Disubstituierte 1,4-Dihydro-4-oxochinolin-Verbindungen | |
| ES2120498T3 (es) | Nuevo compuesto tetraciclico. | |
| NO953396L (no) | Stereoselektiv prosess for fremstilling av dihydro-2,3-benzodiazepinderivater | |
| DE69509231T2 (de) | 3-substituierte pyridinverbindungen und deren derivate als herbizide | |
| DE69213049D1 (de) | Isoquinolinderivate | |
| ATE142201T1 (de) | 2- und 3-amino und azidoderivate von 1,5- iminozuckern als antivirale arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |